Zepp Health Corp (ZEPP)

Zepp Health Corporation is the issuer associated with the NYSE-listed ZEPP depositary receipt for common stock. The company operates globally in the smart wearable and health technology space, focusing on products and digital tools designed to support health, fitness, and wellness tracking. Its consumer brands include Amazfit, Zepp Clarity, and Zepp Aura. Through its Zepp Digital Management Platform, which incorporates Zepp OS, AI chips, biometric sensors, and data algorithms, the company provides cloud-based insights and guidance based on user data. Zepp Health’s product range includes smart bands, watches, scales, rings, and related accessories, as well as smart hearable products, sportswear, home appliances, and smart watch accessories. It also offers Zepp Aura, a personalized sound health solution, along with Zepp Life and Zepp mobile apps that present charts and graphs for activity and biometric analysis. The company markets products in about 90 countries and was formerly known as Huami Corporation before adopting the Zepp Health Corporation name in February 2021. Founded in 2013, it is based in Gorinchem, the Netherlands.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score
NYSE-ZEPP
$5.47
27.2% Upside
Undervalued
$53.01 1,132.8% Upside
Not available
Bargain
Weak
0.0%
November 23, 2026
0.3x
0.2x
63.059 M
129 M
67.6%
41.7%
2.7
Valuation • Fair Value

Zepp Health Corp (NYSE-ZEPP) Fair Value by Valuation Model

Review the available estimates for Zepp Health Corp (NYSE-ZEPP), including Comps Fair Value.

Primary Valuation Read

Fair Value

$5.47

Estimated upside of 27.2% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$5.47

Comparable-company valuation reference.

Analyst Price Target

$53.01 1,132.8% Upside

Current consensus analyst target, where available.

How to read these valuation models

Use the 4 available valuation references for Zepp Health Corp (NYSE-ZEPP) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Zepp Health Corp (NYSE-ZEPP)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

276 M

Current operating scale indicator.

Revenue Forecast

316.1 M

Forward revenue estimate.

EBITDA

-30.458 M

Current operating profitability reference.

EBITDA Forecast

-790.365 K

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Zepp Health Corp (NYSE-ZEPP) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Zepp Health Corp (NYSE-ZEPP)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.78

No elevated caution signal from this screen.

Altman Z-Score

2.7

Intermediate risk zone.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Zepp Health Corp (NYSE-ZEPP). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Zepp Health Corp (NYSE-ZEPP)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 23, 2026

Days to Earnings

62

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Zepp Health Corp (NYSE-ZEPP), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Zepp Health Corp (NYSE-ZEPP) Stock Forecast & Technical Outlook

Review Zepp Health Corp (NYSE-ZEPP) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Zepp Health Corp (NYSE-ZEPP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Zepp Health Corp (NYSE-ZEPP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Zepp Health Corp (NYSE-ZEPP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Zepp Health Corp (NYSE-ZEPP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Zepp Health Corp (NYSE-ZEPP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Zepp Health Corp (NYSE-ZEPP)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Zepp Health Corp (NYSE-ZEPP) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Zepp Health Corp (NYSE-ZEPP) Stock FAQ

Data-supported answers about Zepp Health Corp (NYSE-ZEPP), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$5.47
Estimated upside 27.2%
Valuation Rating
Undervalued
Estimated upside of 27.2%
Analyst Target
$53.01 1,132.8% Upside
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Zepp Health Corp (NYSE-ZEPP) is $5.47. This implies an estimated upside of 27.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 27.2% versus the current market price.

The available analyst price target for Zepp Health Corp (NYSE-ZEPP) is $53.01 1,132.8% Upside.

The current financial health read for Zepp Health Corp (NYSE-ZEPP) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Zepp Health Corp (NYSE-ZEPP) is November 23, 2026.

The latest available data indicates no current dividend yield for Zepp Health Corp (NYSE-ZEPP).

The current market capitalization listed for Zepp Health Corp is 63.059 M.

The current enterprise value listed for Zepp Health Corp is 129 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Zepp Health Corp is NYSE-ZEPP, and the stock is listed on NYSE.

Zepp Health Corp (NYSE-ZEPP) is listed on NYSE.

The current debt-to-total-capital ratio listed for Zepp Health Corp is 67.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Zepp Health Corp is 41.7%. Free float helps investors understand how much of the share base is available for public trading.